Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1085699

MANIDIPINE 6300
🧪 Phase III
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase III
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1

Basic Information

ChEMBL ID CHEMBL1085699
Name MANIDIPINE 6300
Phase Phase III
Structure Type MOL
InChI Key ANEBWFXPVPTEET-UHFFFAOYSA-N

Known Names

Artedil Franidipine Manidipine Manidipine 6300 Manidipino
3
Targets
5
Activities
1
Assay Types
1
PK Parameters
20
Publications
5
Known Names
2
Indications
1
Mechanisms

Molecular Properties

610.7
MW (Da)
4.95
ALogP
9
HBA
1
HBD
114.2
PSA (Ų)
0.19
QED
1
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Racemic

Flags

Natural Product
USAN Stem -dipine; -pine

Extended Properties

Molecular Formula C35H38N4O6
MW 610.71
Aromatic Rings 3
Heavy Atoms 45
NP-Likeness -1.04

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Voltage-gated L-type calcium channel blocker BLOCKER Voltage-gated L-type calcium channel

Indications

Cardiovascular Diseases Hypertension

ATC Classification

C08CA11
manidipine
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CALCIUM CHANNEL BLOCKERS

Activity Summary

IC50 5 meas. best 5.7

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.7 5.51 2000.0 2
ATP-dependent translocase ABCB1
CHEMBL4302
IC50 5.34 5.335 4600.0 2
Cruzipain
CHEMBL3563
IC50 5.22 5.22 6000.0 1

Pharmacokinetic Data

Parameter Value Units Species
CL 93.4 mL.min-1.g-1 Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
34812616 10.1021/acs.jmedchem.1c01547 Unchecked 4
33324471 10.1021/acsmedchemlett.0c00521 Unchecked 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
37468498 10.1038/s41467-023-40064-9 Nuclear receptor subfamily 1 group I member 2 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 Beta-2 adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Beta-1 adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 2
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
20426472 10.1021/jm100254w Cruzipain 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
20426472 10.1021/jm100254w No relevant target 2
37468498 10.1038/s41467-023-40064-9 Androgen receptor 1
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 1

Data from ChEMBL 36 via Core Engine